The bears seized control of trading on Tuesday sending the Dow sharply lower as mixed economic data and disappointing sales from Best Buy sparked worries about a recovery.
As healthcare lands squarely in Washington’s sights, how should you play the sector?
Stocks advanced Thursday, but ended well off their earlier highs, amid weakness in techs and consumer discretionary as oil topped $73 a barrel.
To almost no one's surprise, for the first time in 41 years, the World Health Organization has declared a full-blown swine flu pandemic. But the declaration is tied more to the geographic spread of the virus than it is to its virulence.
Stocks remained higher Thursday but pulled back somewhat after strong demand for the latest 30-year Treasury auction.
Stocks opened slightly higher Thursday after reports showed jobless claims fell last week and retail sales ticked higher in May.
Futures wavered Thursday as a quick pop after the surprise drop in jobless claims fizzled out.
It’s bathing suit time. Considering almost no one likes how they look nearly naked, what’s the trade?
For people struggling with diabetes, the bathroom scale can be the enemy. But new developments may change that and more!
Cramer makes the call on viewers' favorite stocks.
How will male General Motors retirees get their motor runnin'? Do they start paying for their impotence drugs out of their own pocket? Because apparently, under the new deal the company won't pick up the tab anymore.
I've got new competition. Sort of. GlaxoSmithKline sent me an email this morning calling my attention to its new external blog, "American Health: More Than Medicine." A pretty long name for a blog, one that screams that it went through the corporate approval wringer, but at least GSK is putting itself out there.
Even though Warren Buffett always says he likes stocks more when they're cheaper, he didn't do a lot of buying as Wall Street's major indexes fell to their bear-market lows (so far) in early March. Berkshire Hathaway's first quarter stock portfolio snapshot shows no blockbuster buys. A few stakes did, however, get bigger during the first three months on the year.
The World Health Organisation warned on Friday against a false sense of security from waning and apparently mild outbreaks of H1N1 flu, saying the worst may not be over.
The Glaxo announcement contained the results of the first head-to-head study of GSK’s Cervarix versus Merck’s Gardasil. They’re the shots for the sexually transmitted virus that can cause genital warts and cervical cancer. MRK’s is already on the market. GSK’s has been delayed in getting there.
A new study shows that Merck's Gardasil vaccine protects some young women from a strain of a sexually transmitted disease that can lead to cervical cancer for nearly a decade.
Mexico has lowered its estimated death toll from new influenza strain referred to as swine flu to 101 from as many as 176. Italy reported its first case of the H1N1 virus.
Investors can benefit from certain health care companies that will be boosted by the stimulus package, said Les Funtleyder, health care strategist of Miller Tabak.
Investors have a new variable that could potentially impact investment outcomes -- the flu. Your portfolio strategy will be impacted depending on how serious the spread of swine flu is and how dramatic the resulting panic turns out to be.
Here we go again. When I was relatively new on this beat I was thrown into covering the bird flu scare. At the time, many experts said it wasn't a question of if, but when it would come to the U.S. I'm still waiting. And I hope we're all waiting forever.